HYDROXAMATE SULFONAMIDES AS CD23 SHEDDING INHIBITORS
申请人:Celltech R & D Limited
公开号:EP1641771A1
公开(公告)日:2006-04-05
[EN] HYDROXAMATE SULFONAMIDES AS CD23 SHEDDING INHIBITORS<br/>[FR] SULFONAMIDES D'HYDROXAMATE SERVANT D'INHIBITEURS D'ELIMINATION DU VIRUS CD23
申请人:CELLTECH R&D LTD
公开号:WO2004113312A1
公开(公告)日:2004-12-29
A class of piperazine and related heterocyclic derivatives, substituted at the 4-position by a substituted aryl or heteroaryl moiety, and at the 1-position by an ethylsulfonyl group which in turn is substituted at the 2-position by a hydroxamic acid moiety and also by a range of alternative substituents, being potent inhibitors of CD23 shedding, are useful in the treatment and/or prevention of allergic, inflammatory and neoplastic diseases.
Hydroxamate sulfonamides as cd23 shedding inhibitors
申请人:Owen Alan David
公开号:US20060241118A1
公开(公告)日:2006-10-26
A class of piperazine and related heterocyclic derivatives, substituted at the 4-position by a substituted aryl or heteroaryl moiety, and at the 1-position by an ethylsulfonyl group which in turn is substituted at the 2-position by a hydroxamic acid moiety and also by a range of alternative substituents, being potent inhibitors of CD23 shedding, are useful in the treatment and/or prevention of allergic, inflammatory and neoplastic diseases.